International Journal of Health Policy and Management

Main Subjects = Health Policy

Whistleblowing: Don’t Encourage It, Prevent It; Comment on “Cultures of Silence And Cultures of Voice: The Role Of Whistleblowing in Healthcare Organisations”

Volume 5, Issue 3, 2016, Pages 189-191

10.15171/ijhpm.2015.190

D. Robert MacDougall

Policies and Processes for Social Inclusion: Using EquiFrame and EquIPP for Policy Dialogue; Comment on “Are Sexual and Reproductive Health Policies Designed for All? Vulnerable Groups in Policy Documents of Four European Countries and Their Involvement in Policy Development”

Volume 5, Issue 3, 2016, Pages 193-196

10.15171/ijhpm.2015.200

Malcolm MacLachlan; Hasheem Mannan; Tessy Huss; Alister Munthali; Mutamad Amin

Global Health Warning: Definitions Wield Power; Comment on “Navigating Between Stealth Advocacy and Unconscious Dogmatism: The Challenge of Researching the Norms, Politics and Power of Global Health”

Volume 5, Issue 3, 2016, Pages 207-209

10.15171/ijhpm.2015.213

Robert Marten

Future Challenges and Opportunities in Online Prescription Drug Promotion Research; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”

Volume 5, Issue 3, 2016, Pages 211-213

10.15171/ijhpm.2016.05

Brian G. Southwell; Douglas J. Rupert

Single Versus Multi-Faceted Implementation Strategies – Is There a Simple Answer to a Complex Question? A Response to Recent Commentaries and a Call to Action for Implementation Practitioners and Researchers

Volume 5, Issue 3, 2016, Pages 215-217

10.15171/ijhpm.2015.214

Gill Harvey; Alison Kitson

The Pill Really Can Be Mightier Than the Sword: A Response to Recent Commentaries

Volume 5, Issue 3, 2016, Pages 219-220

10.15171/ijhpm.2016.02

Malcolm Potts; Alisha Graves

Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece – the HOPE II Study

Volume 5, Issue 2, 2016, Pages 83-89

10.15171/ijhpm.2015.173

Kyriakos Souliotis; Elena Alexopoulou; Manto Papageorgiou; Anastasia Politi; Panagiota Litsa; Xenophon Contiades

Attitude of Iranian Medical Oncologists Toward Economic Aspects, and Policy-making in Relation to New Cancer Drugs

Volume 5, Issue 2, 2016, Pages 99-105

10.15171/ijhpm.2015.186

Rajabali Daroudi; Mehrzad Mirzania; Kazem Zendehdel

Bomb or Boon: Linking Population, People and Power in Fragile Regions; Comment on “The Pill Is Mightier Than the Sword”

Volume 5, Issue 2, 2016, Pages 109-111

10.15171/ijhpm.2015.176

Raymond Gilpin

A Little Bit of Sugar Helps the Pill Go Down: Resilience, Peace, and Family Planning; Comment on “The Pill Is Mightier Than the Sword”

Volume 5, Issue 2, 2016, Pages 113-116

10.15171/ijhpm.2015.175

Roger-Mark De Souza

Politics and Power in Global Health: The Constituting Role of Conflicts; Comment on “Navigating Between Stealth Advocacy and Unconscious Dogmatism: The Challenge of Researching the Norms, Politics and Power of Global Health”

Volume 5, Issue 2, 2016, Pages 117-119

10.15171/ijhpm.2015.188

Clemet Askheim; Kristin Heggen; Eivind Engebretsen

Optimisation of Healthcare Contracts: Tensions Between Standardisation and Innovation; Comment on “Competition in Healthcare: Good, Bad or Ugly?”

Volume 5, Issue 2, 2016, Pages 121-123

10.15171/ijhpm.2015.189

Misja Mikkers; Padhraig Ryan

What About Leadership?; Comment on “Cultures of Silence and Cultures of Voice: The Role of Whistleblowing in Healthcare Organisations”

Volume 5, Issue 2, 2016, Pages 125-127

10.15171/ijhpm.2015.193

John Blenkinsopp; Nicholas Snowden

When Whistle-blowers Become the Story: The Problem of the ‘Third Victim’; Comment on “Cultures of Silence and Cultures of Voice: The Role of Whistleblowing in Healthcare Organisations”

Volume 5, Issue 2, 2016, Pages 133-135

10.15171/ijhpm.2015.197

Justin Waring

Let’s Raise a Half-Full Glass to the Zombie NHS: A Response to Recent Commentaries

Volume 5, Issue 2, 2016, Pages 147-148

10.15171/ijhpm.2015.210

Martin Powell

The Relationship Between the Scope of Essential Health Benefits and Statutory Financing: An International Comparison Across Eight European Countries

Volume 5, Issue 1, 2016, Pages 13-22

10.15171/ijhpm.2015.166

Philip J. van der Wees; Joost J.G. Wammes; Gert P. Westert; Patrick P.T. Jeurissen

Is It More Important to Address the Issue of Patient Mobility or to Guarantee Universal Health Coverage in Europe?; Comment on “Regional Incentives and Patient Cross-Border Mobility: Evidence From the Italian Experience”

Volume 5, Issue 1, 2016, Pages 47-50

10.15171/ijhpm.2015.163

Helena Legido-Quigley

Policy Capacity for Health Reform: Necessary but Insufficient; Comment on “Health Reform Requires Policy Capacity”

Volume 5, Issue 1, 2016, Pages 51-54

10.15171/ijhpm.2015.164

Owen Adams

The Slow, Lingering Death of the English NHS; Comment on “Who Killed the English National Health Service?”

Volume 5, Issue 1, 2016, Pages 55-57

10.15171/ijhpm.2015.165

David J. Hunter

The Role of Employee Whistleblowing and Raising Concerns in an Organizational Learning Culture – Elusive and Laudable?; Comment on “Cultures of Silence and Cultures of Voice: The Role of Whistleblowing in Healthcare Organisations”

Volume 5, Issue 1, 2016, Pages 67-69

10.15171/ijhpm.2015.182

Aled Jones

What Makes Whistleblowers So Threatening?; Comment on “Cultures of Silence and Cultures of Voice: The Role of Whistleblowing in Healthcare Organisations”

Volume 5, Issue 1, 2016, Pages 71-73

10.15171/ijhpm.2015.183

Charles Frederick Alford

Cross-Border Mobility in Italy: Some Considerations in Response to the Recent Commentaries

Volume 5, Issue 1, 2016, Pages 75-76

10.15171/ijhpm.2015.192

Elenka Brenna

Rights Language in the Sustainable Development Agenda: Has Right to Health Discourse and Norms Shaped Health Goals?

Volume 4, Issue 12, 2015, Pages 799-804

10.15171/ijhpm.2015.171

Lisa Forman; Gorik Ooms; Claire E. Brolan

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters

Volume 4, Issue 12, 2015, Pages 813-821

10.15171/ijhpm.2015.157

Hyosun Kim

Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s)

Volume 4, Issue 12, 2015, Pages 823-829

10.15171/ijhpm.2015.162

Hao Hu; Chao-Chen Chung

International Journal of Health Policy and Management

Journal Archive

Volume 13 (2024)

Volume 12 (2023)

Volume 11 (2022)

Volume 10 (2021)

Volume 9 (2020)

Volume 8 (2019)

Volume 7 (2018)

Volume 6 (2017)

Volume 5 (2016)

Volume 4 (2015)

Volume 3 (2014)

Volume 2 (2014)

Volume 1 (2013)